Handwriting as a marker for PD progression: a shift in paradigm.

Aix-Marseille Universite, CNRS, Laboratoire Parole et Langage (LPL), UMR 7309, Aix-Marseille Universite/CNRS, 5 avenue Pasteur 13100 Aix-en-Provence, France Aix-Marseille Universite, CNRS, Laboratoire de Neurosciences Cognitives (LNC), UMR 7291 Aix-Marseille Universite/ CNRS, 3 place Victor Hugo, 13331 Marseille cedex 03, France *Author for correspondence: Tel.: +33 413 553 623; Fax: + 33 413 553 744; serge.pinto@lpl-aix.fr **Author for correspondence: Tel.: +33 413 551 174; Fax: + 33 413 550 958; jean-luc.velay@univ-amu.fr

[1]  M. Ebadi,et al.  Biomarkers in Parkinson’s disease (recent update) , 2013, Neurochemistry International.

[2]  A. Singleton,et al.  The Parkinson Progression Marker Initiative (PPMI) , 2011, Progress in Neurobiology.

[3]  Jean-Luc Velay,et al.  Signal-to-noise velocity peaks difference: a new method for evaluating the handwriting movement fluency in children with dysgraphia. , 2013, Research in developmental disabilities.

[4]  Normand Teasdale,et al.  What can indices of handwriting quality tell us about Parkinsonian handwriting , 1991 .

[5]  Serge Pinto,et al.  From micrographia to Parkinson's disease dysgraphia , 2014, Movement disorders : official journal of the Movement Disorder Society.

[6]  G E Stelmach,et al.  Micrographia in Parkinson's disease. , 1995, Neuroreport.

[7]  Songthip Ounpraseuth,et al.  Micrographia and related deficits in Parkinson's disease: a cross-sectional study , 2012, BMJ Open.

[8]  Won Yong Lee,et al.  Micrographia on free writing versus copying tasks in idiopathic Parkinson's disease. , 2005, Parkinsonism & related disorders.

[9]  H. Hampel,et al.  Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics , 2011, Journal of Neural Transmission.

[10]  R. Nussbaum,et al.  Alzheimer's disease and Parkinson's disease. , 2003, The New England journal of medicine.

[11]  S. Fahn Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[12]  R. Schwab,et al.  Micrographia in Parkinson's disease. , 1972, Journal of the neurological sciences.

[13]  V. S. Chakravarthy,et al.  A computational model of Parkinsonian handwriting that highlights the role of the indirect pathway in the basal ganglia. , 2009, Human movement science.

[14]  Stephan P. Swinnen,et al.  Relearning of writing skills in Parkinson's disease: A literature review on influential factors and optimal strategies , 2013, Neuroscience & Biobehavioral Reviews.

[15]  D. Calne,et al.  Screening Parkinson's disease: A validated questionnaire of high specificity and sensitivity , 1995, Movement disorders : official journal of the Movement Disorder Society.

[16]  S. A. Wilson,et al.  Disorders of motility and muscle tone with special reference to the corpus striatum , 1925 .

[17]  C. Tanner,et al.  A longitudinal program for biomarker development in Parkinson's disease: A feasibility study , 2009, Movement disorders : official journal of the Movement Disorder Society.

[18]  W. Mutch,et al.  A screening and alerting questionnaire for parkinsonism. , 1991, Neuroepidemiology.

[19]  M. Samuel,et al.  Handwriting as an objective tool for Parkinson’s disease diagnosis , 2013, Journal of Neurology.